Tango Therapeutics, Inc. (TNGX) earnings
TNGX earnings moved a median of +1.52% by the close. Quarterly and annual TNGX reports and results, each read against the price at its own news timestamp. Back to the TNGX overview →
25 measured TNGX earnings events.
Where these TNGX earnings landedvs 25 measured TNGX earnings reactions
| Middle 50% of TNGX earnings reactions | -2.63% to +2.83% |
|---|---|
| Median reaction (to close) | +1.52% |
| Measured reactions | 25 |
Point-in-time · zero look-ahead
Half of the 25 TNGX earnings events with a measured close landed between -2.63% and +2.83%; 68% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Tango Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.79% | -2.63% | |
| Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights | Press release | +0.79% | -2.63% | |
| Form 10-Q Tango Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.47% | +2.77% | |
| Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights | Press release | +1.47% | +2.77% | |
| Form 10-K Tango Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.74% | +37.95% | |
| Tango Therapeutics to Report Fourth Quarter 2025 Financial Results and Participate in Three Upcoming Investor Conferences | Press release | +0.86% | -3.35% | |
| Form 10-Q Tango Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.89% | +1.52% | |
| Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights | Press release | +0.89% | +1.52% | |
| Tango Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 | Press release | -2.70% | +0.64% | |
| Form 10-Q Tango Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.98% | +2.83% | |
| Tango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights | Press release | -2.98% | +2.83% | |
| Tango Therapeutics to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025 | Press release | -1.25% | -1.76% | |
| Form 10-Q Tango Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +4.70% | +11.97% | |
| Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights | Press release | +4.70% | +11.97% | |
| Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025 | Press release | -1.50% | +6.01% | |
| Form 10-K Tango Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +1.72% | -6.44% | |
| Form 10-Q Tango Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +17.37% | +6.23% | |
| Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights | Press release | +17.37% | +6.23% | |
| Form 10-Q Tango Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.01% | -11.83% | |
| Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights | Press release | -1.01% | -11.83% | |
| Form 10-Q Tango Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.08% | +2.73% | |
| Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights | Press release | -2.08% | +2.73% | |
| Form 10-K Tango Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.29% | -3.67% | |
| Form 10-Q Tango Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.82% | +0.90% | |
| Tango Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Highlights | Press release | -2.82% | +0.90% |
Keep exploring
More TNGX: analyst actions → · SEC filings → · TNGX overview →